CMIC Webinars

1. Accelerating Clinical Development In The Asia-Pacific Region 1/13/2023

   Learn from industry experts on the market insights and tips for your successful clinical development in Japan and China.

2. Accelerating Clinical Development In Japan And China: Pricing, Inspection And Regulatory Trends 1/13/2023

   The APAC market has a large treatment naïve population, and has shown improvements in the regulatory environment. Discover insights and tips for successful clinical development in the APAC region

3. Contingency Planning For The Pharmaceutical Industry: How To Reduce Disruption, Downtime, And Profit Loss 1/12/2023

   The COVID-19 global pandemic took the world by storm, disrupting several industries and our global supply chains. Learn why having a contingency plan and proactively planning gives a company a competitive edge. 

4. Current Trends In Oncology Development: How To Navigate Regulatory Hurdles And Accelerate Your Trials 1/12/2023

   Explore how to navigate the regulatory hurdles and accelerate oncology clinical trials by making the right connections within the oncology field.

5. Frontier Of mRNA Drug Discovery: Cancer treatment Using mRNA And Its Future Prospects 1/12/2023

   Explore why mRNA therapeutics has already become a focus area with joint efforts from pharmaceutical companies worldwide.

6. Prophylactic And Therapeutic Applications Of mRNA Technology For Infectious Diseases 1/12/2023

   In recent years, attempts to utilize messenger RNA (mRNA) for medicines are actively increasing worldwide. Since mRNA can produce any protein in theory, it is expected to have a wide range of clinical applications.

7. Make The Impossible Possible: Case Study OF An Innovative Partnership For Market Entry 1/12/2023

   Discover how two partners accelerated the introduction of innovative medicines to treat rare diseases in Japan.

8. Orphan Drug Development In Japan: How Can We Accelerate Rare Disease Patients’ Access To Therapies? 1/12/2023

   Delve into how Japanese rare disease market has a potential for growth, judging by the market growth of US and other dominant countries in EU, as nearly half of orphan drugs approved in Japan come from those countries.

9. Overcoming Challenges Of Bioanalytical Method Development For Oligonucleotides And Large Molecules 1/12/2023

   Gain insight into developing an immunogenicity assay in a regulated laboratory, selecting a format for the neutralization assay for immunogenicity assessments, and quantitative bioanalysis of oligonucleotides by LC-MS.

10. Tips To Ensure Market Entry Success In Japan: Challenges, Regulatory Updates And Success Factors 1/12/2023

    Focus on an overview of the Japanese pharmaceutical market, its unique characteristics, regulatory updates and market entry options.